3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
10
Gastrointestinal
6
Thoracic
4
Lymphoid
3
Other
2
Plasma cell
1
Other hematologic neoplasm
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Classical hematology
1
CNS
1
Conditions
Multiple Myeloma
494
Lymphoma
52
Recurrence
49
Neoplasms, Plasma Cell
49
Immunoglobulin Light-chain Amyloidosis
43
Neoplasms
35
Lymphoma, Non-Hodgkin
35
Leukemia
34
Hematologic Neoplasms
32
Myelodysplastic Syndromes
28
Smoldering Multiple Myeloma
27
Leukemia, Myeloid, Acute
26
Leukemia, Plasma Cell
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Monoclonal Gammopathy of Undetermined Significance
18
Hodgkin Disease
18
Leukemia, Lymphocytic, Chronic, B-Cell
17
Amyloidosis
17
Lymphoma, B-Cell
15
Breast Neoplasms
14
Ovarian Neoplasms
12
Paraproteinemias
11
Myeloproliferative Disorders
10
Colorectal Neoplasms
10
Primary Myelofibrosis
9
Melanoma
9
Lymphoma, Follicular
9
Infections
9
Prostatic Neoplasms
8
Lymphoproliferative Disorders
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Inflammation
×
Plasma cell
×
Clear all
NCT07268846
2025-12-08
POSBIO-CRC
AC Camargo Cancer Center
Phase NA
Recruiting
164 enrolled